Helical

Name: Helical
Brand: Helical

Helical is the virtual AI lab for pharma.

Est 1972|1 Ref Customers

LinkedIn 6K|Web traffic 1K|FTEs 26

MarketsData Science & Machine Learning Platforms

01Competitive Landscape

Narrative analysis

Where Helical appears to differentiate - Vendor materials position the product around Bio Foundation Models as core components rather than as an ancillary feature. - The two-surface design (Virtual Lab + Model Factory) suggests an intent to reduce friction between computational and translational teams. Where competitors may be stronger - Benchling is commonly selected when primary needs are R&D operations, ELN/registry, collaboration, and compliance workflows rather than BFM-specific in-silico experimentation. - DNAnexus is often favored for secure, scalable genomics pipelines and data governance; BFM orchestration can be implemented on top, but may require additional engineering. - NVIDIA BioNeMo-based approaches may be preferable when organizations require fine-grained infrastructure and model control and have in-house ML engineering resources. Adoption / market signals - The vendor has received press attention and reported funding, which indicates activity and momentum. However, the absence of broad public review data limits validation of customer satisfaction at scale.

	Helical	Benchling	DNAnexus
Starting Price	Not publicly listed	Published pricing information available; enterprise pricing typically custom	No simple list price; pricing based on usage/service packages and rate cards
Best For	Pharmaceutical and biotech teams operationalizing BFMs into auditable in-silico workflows (as marketed)	Experimental record, collaboration, registry/inventory; scaling R&D operations	Large-scale genomics data management and workflow execution in secure cloud environments
Key Strength	Emphasis on integrating multiple BFMs and bridging biologist UI with ML engineering environment (vendor claim)	Mature R&D cloud footprint and broad adoption; extensive life-sciences workflow coverage	Proven genomics platform patterns; enterprise governance and workflow execution
Key Weakness	Limited public security/compliance statements and limited third-party reviews; early-stage	May not be purpose-built for BFM orchestration; can be costly or contract-heavy	May require more in-house DS/engineering to build BFM-specific applications

01Competitive Landscape

Narrative analysis

Where Helical appears to differentiate

Vendor materials position the product around Bio Foundation Models as core components rather than as an ancillary feature.
The two-surface design (Virtual Lab + Model Factory) suggests an intent to reduce friction between computational and translational teams.

Where competitors may be stronger

Benchling is commonly selected when primary needs are R&D operations, ELN/registry, collaboration, and compliance workflows rather than BFM-specific in-silico experimentation.
DNAnexus is often favored for secure, scalable genomics pipelines and data governance; BFM orchestration can be implemented on top, but may require additional engineering.
NVIDIA BioNeMo-based approaches may be preferable when organizations require fine-grained infrastructure and model control and have in-house ML engineering resources.

Adoption / market signals

The vendor has received press attention and reported funding, which indicates activity and momentum. However, the absence of broad public review data limits validation of customer satisfaction at scale.

	Helical	Benchling	DNAnexus
Starting Price	Not publicly listed	Published pricing information available; enterprise pricing typically custom	No simple list price; pricing based on usage/service packages and rate cards
Best For	Pharmaceutical and biotech teams operationalizing BFMs into auditable in-silico workflows (as marketed)	Experimental record, collaboration, registry/inventory; scaling R&D operations	Large-scale genomics data management and workflow execution in secure cloud environments
Key Strength	Emphasis on integrating multiple BFMs and bridging biologist UI with ML engineering environment (vendor claim)	Mature R&D cloud footprint and broad adoption; extensive life-sciences workflow coverage	Proven genomics platform patterns; enterprise governance and workflow execution
Key Weakness	Limited public security/compliance statements and limited third-party reviews; early-stage	May not be purpose-built for BFM orchestration; can be costly or contract-heavy	May require more in-house DS/engineering to build BFM-specific applications